SCHEMBL30847980

SCHEMBL30847980

[2H]C([2H])([2H])n1nc(F)c2cccc(Br)c21

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 1/20 0.30
▸ BTK Q06187 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27140925 0.88 JAK2 (0.35) JAK2BTK
SCHEMBL31583384 0.73 ESR1 (0.38) JAK2BTK
SCHEMBL27138457 0.70 DDB1 (0.47) —
SCHEMBL30847906 0.70 DDB1 (0.47) —
SCHEMBL30848071 0.70 DDB1 (0.38) —
SCHEMBL13106346 0.68 LMNA (0.43) JAK2BTK
SCHEMBL31583269 0.67 L3MBTL1 (0.34) JAK2BTK
SCHEMBL30706223 0.67 LMNA (0.37) JAK2BTK
SCHEMBL15995385 0.67 DDB1 (0.38) BTK
SCHEMBL26637934 0.67 LMNA (0.37) JAK2BTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4577536-A1 PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY Hotspot Therapeutics, Inc. (US) 2025-07-02 — — EP disclosed
WO-2024044730-A1 PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY HOTSPOT THERAPEUTICS, INC. (US) 2024-02-29 — — WO disclosed
Send feedback